Acyclovir Capsule
NDC Package 55154-0199-0

11-digit billing NDC: 55154019900
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Acyclovir capsules is herpes Zoster Infections: Acyclovir capsules are indicated for the acute treatment of herpes zoster (shingles).Genital Herpes:  Acyclovir capsules are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes.Chickenpox: Acyclovir capsules are indicated for the treatment of chickenpox (varicella). This formulation utilizes a capsule delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-0199 and is authorized under FDA application ANDA074889.

Identification & Billing

NDC Package Code
55154-0199-0
Package Description
10 BLISTER PACK in 1 BAG / 1 CAPSULE in 1 BLISTER PACK
Product Code
55154-0199
11-Digit Billing Format
55154019900
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Acyclovir
Non-Proprietary Name
Acyclovir
Substance Name
Acyclovir
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ACYCLOVIR 200 mg/1
Pharmacologic Class
Usage Information
Herpes Zoster Infections: Acyclovir capsules are indicated for the acute treatment of herpes zoster (shingles).Genital Herpes:  Acyclovir capsules are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes.Chickenpox: Acyclovir capsules are indicated for the treatment of chickenpox (varicella).

Regulatory & Marketing

Labeler Name
Cardinal Health 107, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA074889
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-14-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-0199-0 identifies a specific commercial package of 10 blister pack in 1 bag / 1 capsule in 1 blister pack of Acyclovir, a human prescription drug labeled by Cardinal Health 107, Llc. This capsule is formulated for oral use and contains acyclovir as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on May 14, 2026. The current certification is valid through December 31, 2027.

How is this Cardinal Health 107, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154019900. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-0199-0
11-Digit CMS (5-4-2)
55154-0199-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.